AGM/EGM28 Sept 2026, 03:00 pm
Medicamen Biotech Ltd Holds 33rd AGM, Approves Financials and Dividend
AI Summary
Medicamen Biotech Ltd held its 33rd Annual General Meeting (AGM) on September 26, 2026, conducted via video conferencing. The meeting focused on the adoption of audited standalone and consolidated financial statements for the fiscal year ended March 31, 2026, along with the board and auditor reports. Shareholders also voted on the declaration of a dividend on equity shares. The voting results indicate overwhelming support for all resolutions, with promoters and public shareholders voting in favor. The company also uploaded the AGM proceedings and scrutinizer's report on its website.
Key Highlights
- Medicamen Biotech Ltd conducted its 33rd AGM on September 26, 2026.
- Audited standalone and consolidated financial statements for FY26 were adopted.
- Dividend declaration on equity shares received shareholder approval.
- All resolutions passed with significant majority support.
- AGM proceedings were conducted via video conferencing.
Price Impact
More from MEDICAMEQ